Abstract:Background: Cannabidiol (CBD), a non-psychoactive phytocannabinoid of cannabis, is therapeutically used as an analgesic, anti-convulsant, anti-inflammatory, and anti-psychotic drug. There is a growing concern about the adverse side effects posed by CBD usage. Pregnane X receptor (PXR) is a nuclear receptor activated by a variety of dietary steroids, pharmaceutical agents, and environmental chemicals. In addition to the role in xenobiotic metabolism, the atherogenic and dyslipidemic effects of PXR have been revealed in animal models. CBD has a low affinity for cannabinoid receptors, thus it is important to elucidate the molecular mechanisms by which CBD activates cellular signaling and to assess the possible adverse impacts of CBD on pro-atherosclerotic events in cardiovascular system, such as dyslipidemia. Objective: Our study aims to explore the cellular and molecular mechanisms by which exposure to CBD activates human PXR and increases the risk of dyslipidemia. Methods: Both human hepatic and intestinal cells were used to test if CBD was a PXR agonist via cell-based transfection assay. The key residues within PXR's ligand-binding pocket that CBD interacted with were investigated using computational docking study together with site-directed mutagenesis assay. The C57BL/6 wildtype mice were orally fed CBD in the presence of PXR antagonist resveratrol (RES) to determine how CBD exposure could change the plasma lipid profiles in a PXR-dependent manner. Human intestinal cells were treated with CBD and/or RES to estimate the functions of CBD in cholesterol uptake. Results: CBD was a selective agonist of PXR with higher activities on human PXR than rodents PXRs and promoted the dissociation of human PXR from nuclear co-repressors. The key amino acid residues Met246, Ser247, Phe251, Phe288, Trp299, and Tyr306 within PXR's ligand binding pocket were identified to be necessary for the agonistic effects of CBD. Exposure to CBD increased the circulating total cholesterol levels in mice which was partially caused by the induced expression levels of the key intestinal PXR-regulated lipogenic genes. Mechanistically, CBD induced the gene expression of key intestinal cholesterol transporters, which led to the increased cholesterol uptake by intestinal cells. Conclusion: CBD was identified as a selective PXR agonist. Exposure to CBD activated PXR signaling and increased the atherogenic cholesterol levels in plasma, which partially resulted from the ascended cholesterol uptake by intestinal cells. Our study provides potential evidence for the future risk assessment of CBD on cardiovascular disease, such as dyslipidemia.

Cholesterol Regulates Cannabinoid Analgesia Through Glycine Receptors.

Membrane Cholesterol Dependence of Cannabinoid Modulation of Glycine Receptor

Correction: Divergent Modulation of Pain and Anxiety by GABAergic Neurons in the Ventrolateral Periaqueductal Gray and Dorsal Raphe.

Involvement of Glycine Receptor Α1 Subunits in Cannabinoid-Induced Analgesia.

Cannabinoid Potentiation of Glycine Receptors Contributes to Cannabis-Induced Analgesia.

Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.

The Non-Psychoactive Plant Cannabinoid, Cannabidiol Affects Cholesterol Metabolism-Related Genes in Microglial Cells

Cholesterol differentially modulates the activity of opioid and muscarinic receptors via common non-canonical binding site

Cholesterol regulates micro-opioid receptor-induced beta-arrestin 2 translocation to membrane lipid rafts.

Modulation of the Cys-loop Ligand-Gated Ion Channels by Fatty Acid and Cannabinoids.

Differential regulation of Cav 3.2 and Cav 2.2 calcium channels by CB1 receptors and cannabidiol

Epigenetic Suppression of Liver X Receptor Β in Anterior Cingulate Cortex by HDAC5 Drives CFA-induced Chronic Inflammatory Pain

The Cannabinoid Dehydroxylcannabidiol Suppresses Neuropathic Pain by Upregulating a Spinal Glycine Receptor-Mediated Compensation Mechanism

Physiological profiling of cannabidiol reveals profound inhibition of sensory neurons

Cannabidiol promotes intestinal cholesterol uptake mediated by Pregnane X receptor

Functional expression of glycine receptors in DRG neurons of mice

Depletion of membrane cholesterol modifies structure, dynamic and activation of Na 1.7

Effects of Cholesterol Levels on the Excitability of Rat Hippocampal Neurons

Inhibition of sodium conductance by cannabigerol contributes to a reduction of dorsal root ganglion neuron excitability

Cannabinoids Regulate Intestinal Motor Function and Electrophysiological Activity of Myocytes in Rodents

Modulation of spinal GABAergic analgesia by inhibition of chloride extrusion capacity in mice